In this paper we explored the role of two emerging anti-metastatic targets involved in collagen matrix homeostasis, Endo180 and LOX, in directing the plasticity of metastatic prostate cancer cells on human ECM surfaces. This evidence concerns the gene MRC2 and prostate cancer.